These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12392586)

  • 41. Acute vascular effects of vascular endothelial growth factor inhibition in the forearm arterial circulation.
    Cameron AC; Welsh P; Neves KB; Newby DE; Touyz RM; Lang NN
    J Hypertens; 2020 Feb; 38(2):257-265. PubMed ID: 31449168
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults.
    Stauffer BL; Westby CM; Greiner JJ; Van Guilder GP; Desouza CA
    Am J Physiol Regul Integr Comp Physiol; 2010 Feb; 298(2):R261-5. PubMed ID: 19939973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vascular effects of endothelin-1 in humans and influence of calcium channel blockade.
    Kiowski W; Linder L; Erne P
    J Hypertens Suppl; 1994 Jan; 12(1):S21-6. PubMed ID: 8207561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Persistence of sympathetic-mediated forearm vasoconstriction after alpha-blockade in hypertensive patients.
    Taddei S; Salvetti A; Pedrinelli R
    Circulation; 1989 Sep; 80(3):485-90. PubMed ID: 2569947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Local angiotensin-converting enzyme inhibition blunts endothelin-1-induced increase in forearm vascular resistance.
    Abernethy DR; Laurie N; Andrawis NS
    Clin Pharmacol Ther; 1995 Sep; 58(3):328-34. PubMed ID: 7554707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intra-arterial infusion of insulin attenuates vasoreactivity in human forearm.
    Sakai K; Imaizumi T; Masaki H; Takeshita A
    Hypertension; 1993 Jul; 22(1):67-73. PubMed ID: 8319994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis.
    Helmy A; Jalan R; Newby DE; Johnston NR; Hayes PC; Webb DJ
    Hepatology; 2001 Apr; 33(4):826-31. PubMed ID: 11283846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose- and time-dependency of the dilator effects of the endothelin antagonist, BQ-123, in the human forearm.
    Berrazueta JR; Bhagat K; Vallance P; MacAllister RJ
    Br J Clin Pharmacol; 1997 Dec; 44(6):569-71. PubMed ID: 9431833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor.
    Kiowski W; Lüscher TF; Linder L; Bühler FR
    Circulation; 1991 Feb; 83(2):469-75. PubMed ID: 1846783
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic treatment with long-acting nifedipine reduces vasoconstriction to endothelin-1 in essential hypertension.
    Sudano I; Virdis A; Taddei S; Spieker L; Corti R; Noll G; Salvetti A; Luscher TF
    Hypertension; 2007 Feb; 49(2):285-90. PubMed ID: 17178974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans.
    Böhm F; Settergren M; Gonon AT; Pernow J
    Clin Sci (Lond); 2005 Apr; 108(4):357-63. PubMed ID: 15610070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rho kinase contributes to basal vascular tone in humans: role of endothelium-derived nitric oxide.
    Büssemaker E; Pistrosch F; Förster S; Herbrig K; Gross P; Passauer J; Brandes RP
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H541-7. PubMed ID: 17384125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Haemodynamic effects of adrenomedullin in human resistance and capacitance vessels.
    Cockcroft JR; Noon JP; Gardner-Medwin J; Bennett T
    Br J Clin Pharmacol; 1997 Jul; 44(1):57-60. PubMed ID: 9241097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Witherow FN; Helmy A; Webb DJ; Fox KA; Newby DE
    Circulation; 2001 Oct; 104(18):2177-81. PubMed ID: 11684627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endothelin-1-mediated vasoconstriction at rest and during dynamic exercise in healthy humans.
    Wray DW; Nishiyama SK; Donato AJ; Sander M; Wagner PD; Richardson RS
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2550-6. PubMed ID: 17693542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin converting enzyme inhibition does not affect the response to exogenous angiotensin II in the human forearm.
    Lyons D; Stewart D; Webster J; Benjamin N
    Br J Clin Pharmacol; 1994 Nov; 38(5):417-20. PubMed ID: 7893582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vasoconstriction to endogenous endothelin-1 is impaired in patients with type II diabetes mellitus.
    McAuley DF; Nugent AG; McGurk C; Maguire S; Hayes JR; Johnston GD
    Clin Sci (Lond); 2000 Sep; 99(3):175-9. PubMed ID: 11787468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vasoconstriction to endogenous endothelin-1 is increased in the peripheral circulation of patients with essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Sudano I; Notari M; Salvetti A
    Circulation; 1999 Oct; 100(16):1680-3. PubMed ID: 10525485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of calcitonin gene-related peptide (CGRP) on human forearm blood flow.
    Jernbeck J; Edner M; Dalsgaard CJ; Pernow B
    Clin Physiol; 1990 Jul; 10(4):335-43. PubMed ID: 2394085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heterogeneous vascular response to vasopressin: radial artery versus forearm blood flow.
    Hayoz D; Weber R; Pechère A; Burnier M; Brunner HR
    J Hypertens; 1997 Jan; 15(1):35-41. PubMed ID: 9050968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.